Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus‐infected patients with renal impairment - Suda, Goki; Nagasaka, Atsushi; Yamamoto, Yoshiya; Furuya, Ken; Kumagai, Kenichi; Kudo, Mineo; Terashita, Katsumi; Kobayashi, Tomoe; Tsunematsu, Izumi; Yoshida, Junichi; Meguro, Takashi; Kimura, Megumi; et al. (Hepatology research, 2017)
Keywords: Alanine; Alanine transaminase; Anemia; Antiviral agents; asunaprevir; daclatasvir; direct‐acting antiviral; End-stage renal disease; Epidermal growth factor receptors; Glomerular filtration rate; Graft rejection; Grafts; Hemodialysis; Hepatitis; Hepatitis C; hepatitis C virus; Kidney diseases; Kidney transplantation; Renal failure; Renal function; Ribonucleic acid; RNA; hepatitis C virus; direct-acting antiviral; asunaprevir; daclatasvir